A Study of FWD1509 in Adults With Non-Small Cell Lung Cancer
Clinical trial NCT05068024 · UNKNOWN
Trial details
- NCT number
- NCT05068024
- Sponsor
- Forward Pharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-23
- Primary completion
- 2022-10-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.